Blueweave
Saudi Arabia Solid Tumor Testing Market

Saudi Arabia Solid Tumor Testing Market

Saudi Arabia Solid Tumor Testing Market - By Type (Conventional Testing, Genetic testing); By Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Cervical Cancer); By Application (Hospitals, Diagnostic Laboratories, Academic and Research Institutes, Others), Trend Analysis, Competitive Landscape & Forecast, 2019–2029

  • Published Date: January 2023
  • Report ID: BWC23013
  • Available Format: PDF
  • Page: 240

Report Overview

Unhealthy lifestyles, rise in demand for minimally invasive procedures for solid tumor diagnosis, growing geriatric population, and technology advancements boost the growth of Saudi Arabia Solid Tumor Testing Market during the forecast period between 2023 and 2029.

Saudi Arabia Solid Tumor Testing Market - Industry Trends & Forecast Report, 2029

Saudi Arabia solid tumor testing market size is expected to grow at a CAGR of 6.10% during the forecast period between 2023 and 2029. One of the major factors driving the growth of the solid tumor testing market is the increase in the number of cancer patients. Widespread use of spatial techniques in cancer research and diagnosis, as well as the introduction of novel technologies to reduce errors, are driving market growth. Increased number of market players dealing in these technologies, as well as the development of high-throughput, rapid, sensitive, and multi-parametric solutions for prognosis, diagnostics, and treatment, all have an impact on the market. Increase in investments, grants, and funds, an increase in population, an increase in healthcare expenditure, and an increase in funding support from various organizations all have a positive impact on the solid tumor testing market. The increasing demand for personalized medicine provides market with a profitable opportunity.

Saudi Arabia Solid Tumor Testing Market - Overview

A solid tumor is a developed solid mass that can occur on any part of the body. Cancer of the solid tumor is a condition in which abnormal cells divide uncontrollably. Cancer is the third most lethal disease in the world, after cardiovascular and infectious diseases. Solid tumors can develop on any organ or bone. In medical terms, not all solid tumors are cancerous, but solid tumors containing cancerous cells are called malignant tumors. Cancer of the lungs, breasts, skin, head, neck, colon, prostate, and bladder are examples of solid tumor cancer.

Growth Drivers

Increasing Prevalence of Various Cancer Types

Rising prevalence of various types of metastatic cancer is expected to contribute to market growth. The prevalence of multiple cancerous conditions is increasing daily. Lung, colorectal, breast, and liver cancers will necessitate additional tumor testing, further pushing the market. Brain and neuroblastomas are the most common types of solid tumors; rhabdomyosarcoma and osteosarcoma are less common types of solid cancers.

Increasing R&D Investments to Drive the Market

Another important factor that has a significant impact on the growth rate of the solid tumors market is the rising cost of healthcare, which helps to improve the industry's overall infrastructure. The market dynamics will change because of numerous government organizations' efforts to improve healthcare infrastructure by increasing funding. The market for solid tumors will also grow as a result of increased awareness-raising efforts by both public and private organizations and rising demand for highly effective chemotherapeutic drugs. The market will expand because of both factors. The rising prevalence of multiple cases of solid tumors and people's increasingly sedentary lifestyles are additional factors influencing the growth of the solid tumor market. Market is expected to grow significantly as a result of rising levels of discretionary income and an aging population.

Restraints

High Treatment Costs and Insufficient Number of Trained Professionals

High cost of finishing the treatment will slow the market's growth rate. The solid tumor market will be challenged by the problem of developing economies' insufficient healthcare infrastructure and a shortage of qualified medical professionals. The market's growth rate will also be limited and hampered by stringent regulatory policies and a general lack of public awareness. Such factors will stifle market growth shortly.

Impact of COVID-19 on Saudi Arabia Solid Tumor Testing Market

The Covid-19 pandemic had an impact on the Saudi Arabia solid tumor testing market, but the market has since experienced significant growth. The market for solid tumor cancer treatments is expected to grow during the forecast period due to several driving factors. One of the key market drivers is the development of therapies for the treatment of solid tumor cancer. Another factor driving the solid tumor cancer treatment market, which has drawn investors, is the increased use of nanomedicines in therapy.

Saudi Arabia Solid Tumor Testing Market

Segmental Coverage

Saudi Arabia Solid Tumor Testing Market - By Type

Saudi Arabia solid tumor market is divided into Conventional Testing and Genetic Testing segments. During the forecast period, genetic testing is expected to grow at a faster rate. The discovery of changes in cancer through biomarker testing, also known as tumor testing, tumor profiling, or tumor genetic testing, may assist the patients and their doctors in determining the best course of treatment.

Saudi Arabia Solid Tumor Testing Market

Saudi Arabia Solid Tumor Testing Market - By Cancer Type

On basis of cancer type, Saudi Arabia solid tumor market is divided into Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, and Cervical Cancer types. The breast cancer segment dominates Saudi Arabia solid tumor market. The most frequent solid tumor in women is breast cancer. All patients with advanced breast cancer, like those with other solid tumors, inevitably develop treatment resistance despite a variety of drug combinations and regimens. Identified resistance mechanisms can be divided into intracellular and extracellular mechanisms.

Saudi Arabia Solid Tumor Testing Market - By Application

On basis of application, Saudi Arabia solid tumor testing market is divided into Hospitals, Diagnostic Laboratories, Academic and Research Institutes, and other segments. Due to the rising incidence of various cancers, hospitals dominate the Saudi Arabia solid tumor testing market treatments that are growing at the fastest rate. By offering specialized centers for the treatment of solid tumor cancer, hospitals are growing. At the same time, research institutions contribute significantly to the expansion of the solid tumor cancer treatment market by offering cutting-edge medications and medical equipment for superior healthcare.

Competitive Landscape

Major players in Saudi Arabia solid tumor market include Abbott, Beckman Coulter/Danaher/Cepheid, Becton Dickinson, bioMérieux, Bio-Rad, DiaSorin, Elitech Group, and Enzo Biochem. The key strategies used by these market leaders are new product launches, mergers & acquisitions, and alliances. To grow their market share, these companies are also focusing on investing in innovations, collaborations, and expansions.

Scope of the Report

Attributes

Details

Years Considered

Historical Data – 2019–2022

Base Year – 2022

Estimated Year – 2023

Forecast Period – 2023–2029

Facts Covered

Revenue in USD Million

Market Coverage

Saudi Arabia

Product/ Service Segmentation

Type, Cancer Type, Application

Key Players

Abbott, Beckman Coulter/Danaher/Cepheid, Becton Dickinson, bioMérieux, Bio-Rad, DiaSorin, Elitech Group, Enzo Biochem

 

By Type

    • Conventional Testing

    • Genetic Testing

By Cancer Type

    • Breast Cancer

    • Lung Cancer

    • Colorectal Cancer

    • Prostate Cancer

    • Cervical Cancer

By Application

    • Hospitals

    • Diagnostic Laboratories

    • Academic and Research Institutes

    • Others

  1. Research Framework
    1. Research Objective
    2. Solid Tumor Testing Overview
    3. Market Segmentation
  2. Executive Summary
  3. Saudi Arabia Solid Tumor Testing Market Insights
    1. Industry Value Chain Analysis
    2. DROC Analysis
      1. Growth Drivers
        1. Increase in Geriatric Population
        2. Increase in the Prevalence of Various Cancer Types to Impede the Market Growth
        3. Increasing Trend of Unhealthy Lifestyles
      2. Restraints
        1. Lack of Skilled Professionals
      3. Opportunities
        1. Rise in Demand for Minimally Invasive Procedure for the Diagnosis of Solid Tumor
        2. Increase in Technology Advancements
      4. Challenges
        1. Stringent Regulations
    3. Technology Advancements/Recent Developments
    4. Regulatory Framework
    5. Porter’s Five Forces Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of New Entrants
      4. Threat of Substitutes
      5. Intensity of Rivalry
  4. Saudi Arabia Solid Tumor Testing Market Overview
    1. Market Size & Forecast, 2019–2029
      1. By Value (USD Million)
    2. Market Share & Forecast
      1. By Type
        1. Conventional Testing
        2. Genetic testing
      2. By Cancer Type
        1. Breast Cancer
        2. Lung Cancer
        3. Colorectal Cancer
        4. Prostate Cancer
        5. Cervical Cancer
      3. By Application
        1. Hospitals
        2. Diagnostic Laboratories
        3. Academic and Research Institutes
        4. Others
  5. Competitive Landscape
    1. List of Key Players and Their Offerings
    2. Saudi Arabia Solid Tumor Testing Company Market Share Analysis, 2022
    3. Competitive Benchmarking, By Operating Parameters
    4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)
  6. Impact of Covid-19 on Saudi Arabia Solid Tumor Testing Market
  7. Company Profile (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, and SWOT Analysis)
    1.  Abbott
    2.  Beckman Coulter/Danaher/Cepheid
    3.  Becton Dickinson
    4.  bioMerieux
    5.  Bio-Rad
    6.  DiaSorin
    7.  Elitech Group
    8. Enzo Biochem
    9. Other Prominent Players
  8. Key Strategic Recommendations
  9. Research Methodology
    1. Qualitative Research
      1.  Primary & Secondary Research
    2.  Quantitative Research
    3.  Market Breakdown & Data Triangulation
      1.  Secondary Research
      2.  Primary Research
    4. Breakdown of Primary Research Respondents, By Region
    5.  Assumptions & Limitations

*Financial information of case of non-listed companies can be provided as per availability.

**The segmentation and the companies are subject to modifications based on in-depth secondary research for the final deliverable.          

 

List Of Figures

 

Figure 1        Saudi Arabia Solid Tumor Testing Segmentation            

Figure 2        Saudi Arabia Solid Tumor Testing Market Value Chain Analysis            

Figure 3        Company Market Share Analysis, 2022               

Figure 4        Saudi Arabia Solid Tumor Testing Market Size, By Value (USD Million), 2019–2029              

Figure 5        Saudi Arabia Solid Tumor Testing Market Share, By Type, By Value, 2019–2029                  

Figure 6        Saudi Arabia Solid Tumor Testing Market Share, By Cancer Type, By Value, 2019–2029                  

Figure 7        Saudi Arabia Solid Tumor Testing Market Share, By Application, By Value, 2019–2029                     

 

 

List Of Tables

 

Table 1         Saudi Arabia Solid Tumor Testing Market Size, By Type, By Value, 2019–2029

Table 2         Saudi Arabia Solid Tumor Testing Market Size, By Cancer Type, By Value, 2019–2029

Table 3         Saudi Arabia Solid Tumor Testing Market Size, By Application, By Value, 2019–2029  

Table 4         Abbott Company Overview 

Table 5         Abbott Financial Overview  

Table 6         Beckman Coulter/Danaher/Cepheid Company Overview 

Table 7         Beckman Coulter/Danaher/Cepheid Financial Overview 

Table 8         Becton Dickinson Company Overview      

Table 9         Becton Dickinson Financial Overview       

Table 10        bioMerieux Company Overview     

Table 11        bioMerieux Financial Overview      

Table 12        Bio-Rad Company Overview

Table 13        Bio-Rad Financial Overview

Table 14        DiaSorin Company Overview        

Table 15        DiaSorin Financial Overview

Table 16        Elitech Group Company Overview 

Table 17        Elitech Group Financial Overview  

Table 18        Enzo Biochem Company Overview

Table 19        Enzo Biochem Financial Overview 

Market Segmentation

By Type

    • Conventional Testing

    • Genetic Testing

By Cancer Type

    • Breast Cancer

    • Lung Cancer

    • Colorectal Cancer

    • Prostate Cancer

    • Cervical Cancer

By Application

    • Hospitals

    • Diagnostic Laboratories

    • Academic and Research Institutes

    • Others

No data available

To request a free sample copy of this report, please complete the form below.

We value your investment and offer free customization with every report to fulfil your exact research needs.

This website is secure and your personal details are safe.